A variety of treatment modalities are available to treat varicose veins/venous insufficiency, including surgical approaches, thermal ablation, and sclerotherapy. The application of each of these treatment options is influenced by the severity of the symptoms, type of vein, source of venous reflux, and the use of other (prior or concurrent) treatments.
General medical necessity criteria for coverage of symptomatic varicose veins
Treatment for symptomatic varicose veins may be considered medically necessary when ALL of the following criteria are met for all varicose vein treatments:
o Gradient compression garments providing a minimum of 20-30 mmHg pressure; and
o Leg elevation; and
o Walking/exercising as tolerated; and
o Clinical, etiology, anatomy, pathophysiology (CEAP) class C2 or greater; and
(Conservative treatment is not required in cases of CEAP levels five (5) and six (6))
Imaging Requirements:
Treatment Sessions:
Follow-up Imaging
Intraoperative ultrasound guidance, when performed, is an integral part of the primary procedure and is not separately reimbursed.
Accepted Procedures
When conservative treatments fail to provide relief from symptomatic venous insufficiency and ALL of the above general criteria requirements are met, the following options may be considered medically necessary when reported for symptomatic varicose veins. However, in addition to the general medically necessary criteria above, specific requirements for each procedure must also be met:
If general medical necessity criteria are not met, see specific procedures and treatment of specific veins below for appropriate denial criteria.
36470 |
36471 |
36475 |
36476 |
36478 |
36479 |
36482 |
36483 |
37500 |
37700 |
37718 |
37722 |
37735 |
37765 |
37766 |
37780 |
37785 |
37799 |
76942 |
76998 |
S2202 |
|
Criteria for Specific Procedures
Cyanoacrylate Adhesive (Great Saphenous, Small Saphenous and Accessory Saphenous Veins)
Treatment of the great saphenous or small saphenous veins with cyanoacrylate adhesive may be considered medically necessary for symptomatic varicose veins/venous insufficiency when ALL of the following criteria are met:
· Great saphenous vein symptoms including but not limited to leg/ankle swelling, skin changes, or a venous stasis ulcer; or
· Small saphenous vein symptoms including but not limited to lateral ankle and foot swelling, or a venous stasis ulcer; and
· ALL of the general medically necessary criteria above are met; and
· One (1) treatment session each of the great saphenous veins; one (1) session for the left great saphenous or one (1) session for the right great saphenous, totaling two (2) sessions; and
· One (1) treatment session each of the small saphenous veins; one (1) session for the left small saphenous or one (1) session for the right small saphenous, totaling two (2) sessions.
Additional procedures including ligation or sclerotherapy performed in the same treatment session on the same treated saphenous vein are included in the reimbursement of the procedure.
Procedures on other saphenous vein systems are eligible for reimbursement based on multiple surgery guidelines.
Treatment of the great saphenous veins and small saphenous veins with cyanoacrylate adhesive not meeting the above criteria is considered cosmetic and therefore non-covered.
For accessory saphenous veins criteria, see Accessory Saphenous Veins.
36482 36483
Echosclerotherapy
Echosclerotherapy is a technique used for perforator veins. Duplex ultrasound guidance is used to inject a sclerosing agent into varicose veins.
Echosclerotherapy may be considered medically necessary when BOTH of the following criteria have been met:
Code S2202 includes the cost of ultrasound guidance therefore when code 76942 is reported in addition to code S2202 no additional allowance will be made.
Echosclerotherapy performed for any other indication is considered not medically necessary.
S2202 |
|
|
|
|
|
|
Endovenous Radiofrequency, Endovenous Laser Ablation/Treatment (EVLA/EVLT) and Endomechanical Ablation
Treatment of the great saphenous veins and small saphenous veins may be considered medically necessary when ALL of the following criteria are met:
Additional procedures including ligation or sclerotherapy performed in the same treatment session on the same ablated saphenous vein are included in the reimbursement of the ablation procedure.
Procedures on other saphenous vein systems are eligible for reimbursement based on multiple surgery guidelines.
Endovenous radiofrequency obliteration of veins (VNUS), laser ablation (EVLT) and endomechanical ablation of incompetent veins include imaging guidance and catheter insertion as part of the overall procedure.
For criteria related to perforator veins, see Perforator Veins
Endovenous ablation procedures for the treatment of the great saphenous and the small saphenous veins for all other conditions are considered cosmetic and therefore non-covered.
36475 |
36476 |
36478 |
36479 |
37799 |
|
|
Ligation and Stripping and Phlebectomy (i.e., Stab, Hook, Transilluminated Powered)
Treatment of the great saphenous veins, small saphenous veins and/or saphenous tributaries may be considered medically necessary when the following criteria are met:
Ambulatory phlebectomy services, procedures codes 37765 and 37766, are reported based on the number of incisions performed on each extremity. When fewer than 10 incisions are required, report code 37799.
Procedure code 37785 includes the ligation, division, and/or excision of one or more varicose vein clusters and should only be reported once per extremity. Report code 37785 with modifier RT, LT, or 50 as appropriate.
Ligation and stripping, ambulatory phlebectomy (i.e., stab, hook, transilluminated powered) for conditions other than symptomatic veins, are considered cosmetic, and therefore, non-covered. This includes the diagnosis of non-symptomatic varicose veins.
37718 |
37722 |
37700 |
37735 |
37765 |
37766 |
37780 |
37785 |
37799 |
|
|
|
|
|
Sclerotherapy (Liquid or Microfoam)
Sclerotherapy may be considered medically necessary for the treatment of the small saphenous veins or saphenous tributaries, including accessory saphenous veins when ALL of the following criteria are met:
Sclerotherapy performed on the small saphenous veins or saphenous tributaries (including saphenous veins) not meeting the criteria above will be considered cosmetic.
Non-covered
Sclerotherapy (liquid or microfoam) of the great saphenous vein and perforator veins is considered experimental/investigational and therefore non-covered due to lack of supporting scientific evidence.
Sclerotherapy (liquid or microfoam) of the following veins is considered cosmetic and therefore non- covered;
Coverage for sclerotherapy (liquid or microfoam) for these indications is limited to a maximum of three (3) sclerotherapy treatment sessions per leg: three (3) treatment sessions for the right leg and three (3) sessions for the left leg. A total of six (6) sessions may be authorized to treat these veins without additional clinical documentation, when performed within 12 months of the initial invasive varicose vein procedure.
Requests for additional sclerotherapy (liquid or microfoam) treatment, extending beyond the maximum three (3) treatment sessions per leg, may be considered medically necessary when ALL of the following additional criteria have been met.
Requests for treatment sessions extending beyond one year (12 months) from the initial invasive treatment session may be similarly subject to a new medical necessity review.
Reimbursement
Code 36470
Code 36471
Code J3490
36465 |
36466 |
36470 |
36471 |
76942 |
J3490 |
Treatments of Specific Vein Types
Accessory Saphenous Veins
Treatment of accessory saphenous veins by ligation and stripping, endovenous radiofrequency, laser ablation or cyanoacrylate adhesive may be considered medically necessary for symptomatic varicose veins/venous insufficiency when ALL of the following criteria have been met:
Non-covered
Treatment of accessory saphenous veins by ligation and stripping, endovenous radiofrequency, or laser ablation, or cyanoacrylate that do not meet the coverage criteria described above is considered cosmetic and therefore non-covered.
36475 |
36476 |
36478 |
36479 |
36482 |
36483 |
37718 |
37722 |
37700 |
37765 |
37766 |
37780 |
37785 |
37799 |
Greater Saphenous Vein Treatments (see Criteria for Specific Procedures above)
Ligation and stripping and phlebectomy (i.e., stab, hook, transilluminated powered), endovenous radiofrequency, endovenous laser ablation/treatment (EVLA/EVLT), endomechanical ablation, or cyanoacrylate adhesive.
36475 |
36476 |
36478 |
36479 |
36482 |
36483 |
37718 |
37722 |
37700 |
37765 |
37766 |
37780 |
37785 |
37799 |
Perforator Veins: Subfascial endoscopic perforator surgery (SEPS) or endovenous radiofrequency or laser ablation may be considered medically necessary as a treatment of leg ulcers associated with chronic venous insufficiency when the following criteria have been met;
Ligation or ablation of incompetent perforator veins performed concurrently with superficial venous surgery is not considered not medically necessary.
SEPS, endovenous radiofrequency or laser ablation performed on perforator veins that do not meet the criteria above will be considered cosmetic and therefore non-covered.
36475 |
36476 |
36478 |
36479 |
37500 |
37799 |
|
Saphenous Tributaries (see Criteria for Specific Procedures above)
Ligation and stripping and phlebectomy (i.e., stab, hook, transilluminated powered) or sclerotherapy (liquid or microfoam).
36465 |
36466 |
36470 |
36471 |
37700 |
37718 |
37722 |
37735 |
37765 |
37766 |
37780 |
37785 |
37799 |
76942 |
J3490 |
|
|
|
|
|
|
Small Saphenous Vein Treatments (see Criteria for Specific Procedures above)
Ligation and stripping and phlebectomy (i.e., stab, hook, transilluminated powered), endovenous radiofrequency, endovenous laser ablation/treatment (EVLA/EVLT), endomechanical ablation or sclerotherapy (liquid or microfoam) or cyanoacrylate
36465 |
36466 |
36470 |
36471 |
36475 |
36476 |
36478 |
36479 |
36482 |
36483 |
37700 |
37718 |
37722 |
37765 |
37766 |
37780 |
37785 |
37799 |
76942 |
J3490 |
|
Non-Covered Services
Endovenous Cryoablation
Endovenous cryoablation of any vein is considered experimental/investigational and therefore non- covered. Scientific evidence does not demonstrate the effectiveness of this treatment.
37799 |
|
|||||
|
Laser Treatment, Non-Invasive
Non-invasive laser treatment, e.g., Vasculite Nd Yag, intense pulsed light (IPL), performed on small superficial, reticular, and telangiectatic veins is considered cosmetic and therefore non-covered.
This method of treatment for larger veins is considered experimental/investigational and therefore non-covered. Scientific evidence does not demonstrate the effectiveness of this treatment.
37799 |
|
|
|
|
|
|
Mechanochemical Ablation (MCA)/(MOCA)
Mechanochemical ablation of any method, of any vein (i.e., ClariVein® system) is considered experimental/investigational and therefore non-covered. Scientific evidence does not demonstrate the safety and efficacy of this treatment.
0524T |
36473 |
36474 |
|
|
|
|
Spider Veins, Treatment
Treatment for reticular veins and/or superficial telangiectasia’s, including laser, is considered cosmetic, and therefore, non-covered.
Procedure codes 17106, 17107, and 17108 should not be used to report the treatment of reticular veins and/or spider veins.
17106 |
17107 |
17108 |
36468 |
37799 |
|
|
CEAP Classification System
Class Definition
C0 No visible or palpable signs of venous disease
C1 Telangiectasies or reticular veins
C2 Varicose veins
C3 Edema
C4a Pigmentation and eczema
C4b Lipodermatosclerosis and atrophie blanche
C5 Healed venous ulcer
C6 Active venous ulcer
Refer to the following Medical Policies for additional information:
Covered diagnosis codes for procedure codes 36465, 36466, 36470, 36471, 36475, 36476, 36478, 36479, 36482, 36483, 37500, 37700, 37718, 37722, 37735, 37765, 37766, 37780, and 37785.
I80.00 |
I80.01 |
I80.02 |
I80.03 |
I83.10 |
I83.11 |
I83.12 |
I83.001 |
I83.002 |
I83.003 |
I83.004 |
I83.005 |
I83.008 |
I83.009 |
I83.011 |
I83.012 |
I83.013 |
I83.014 |
I83.015 |
I83.018 |
I83.019 |
I83.021 |
I83.022 |
I83.023 |
I83.024 |
I83.025 |
I83.028 |
I83.029 |
I83.201 |
I83.202 |
I83.203 |
I83.204 |
I83.205 |
I83.208 |
I83.209 |
I83.211 |
I83.212 |
I83.213 |
I83.214 |
I83.215 |
I83.218 |
I83.219 |
I83.221 |
I83.222 |
I83.223 |
I83.224 |
I83.225 |
I83.228 |
I83.229 |
I83.811 |
I83.812 |
I83.813 |
I83.819 |
I83.891 |
I83.892 |
I83.893 |
I83.899 |
I87.2 |
I87.9 |
|
|
|
|
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical or other circumstances may warrant individual consideration, based on review of applicable medical records, as well as other regulatory, contractual and/or legal requirements.
Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract, and subject to the applicable laws of your state.
Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.
Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:
If you need these services, contact the Civil Rights Coordinator.
If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.
You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:
U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)
Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.
Insurance or benefit/claims administration may be provided by Highmark, Highmark Choice Company, Highmark Coverage Advantage, Highmark Health Insurance Company, First Priority Life Insurance Company, First Priority Health, Highmark Benefits Group, Highmark Select Resources, Highmark Senior Solutions Company or Highmark Senior Health Company, all of which are independent licensees of the Blue Cross and Blue Shield Association, an association of independent Blue Cross and Blue Shield plans.
Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.
Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:
If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.
You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:
U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)
Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.